Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Testing Shortened Versions of Smell Tests to Screen for Hyposmia in Parkinson's Disease.

Auger SD. et al, (2020), Mov Disord Clin Pract, 7, 394 - 398

Deep phenotyping of peripheral tissue facilitates mechanistic disease stratification in sporadic Parkinson's disease.

Carling PJ. et al, (2020), Prog Neurobiol, 187

Fine-Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt Synucleinopathies.

Krohn L. et al, (2020), Ann Neurol, 87, 584 - 598

Genome-Wide Association Study of Pain in Parkinson's Disease Implicates TRPM8 as a Risk Factor.

Williams NM. et al, (2020), Mov Disord, 35, 705 - 707

GBA variants in REM sleep behavior disorder: a multicenter study

HU M., (2020), Neurology

Blood biomarkers with Parkinson's disease clusters and prognosis: The oxford discovery cohort.

Lawton M. et al, (2020), Mov Disord, 35, 279 - 287

Book Review of "Ending Parkinson's Disease: A Prescription for Action".

Hu MT., (2020), J Parkinsons Dis, 10, 743 - 744

Continuous Real-World Gait Monitoring in Idiopathic REM Sleep Behavior Disorder.

Del Din S. et al, (2020), J Parkinsons Dis, 10, 283 - 299

Genetic, Structural, and Functional Evidence Link TMEM175 to Synucleinopathies.

Krohn L. et al, (2020), Ann Neurol, 87, 139 - 153

Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease

Tan MMX. et al, (2020), Movement Disorders

Nigrosome 1 imaging in REM sleep behavior disorder and its association with dopaminergic decline

Barber TR. et al, (2020), Annals of Clinical and Translational Neurology, 7, 26 - 35

Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory Science.

Stephenson D. et al, (2020), Digit Biomark, 4, 28 - 49

Reply to: "Predictors of motor complications in early Parkinson's disease".

Baig F. et al, (2020), Mov Disord, 35

Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.

Jabbari E. et al, (2019), JAMA Neurol

A Qualitative Study on the Impact of First Steps-A Peer-led Educational Intervention for People Newly Diagnosed with Parkinson's Disease.

Soundy A. et al, (2019), Behav Sci (Basel), 9

Fine-mapping of SNCA in REM sleep behavior disorder and overt synucleinopathies

Krohn L. et al, (2019)

RNA sequencing reveals MMP2 and TGFB1 downregulation in LRRK2 G2019S Parkinson's iPSC-derived astrocytes

Booth HDE. et al, (2019), Neurobiology of Disease, 129, 56 - 66

Impulse control disorders in Parkinson disease and RBD: A longitudinal study of severity.

Baig F. et al, (2019), Neurology, 93, e675 - e687

Dementia in Parkinson's disease

HU M. and BAIG F., (2019), New Oxford Textbook Psychiatry 3e

Predictors of motor complications in early Parkinson's disease: A prospective cohort study.

Kelly MJ. et al, (2019), Mov Disord, 34, 1174 - 1183

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?